Abstract
Briefly, the underlying physiological principles of stress-rest perfusion imaging are as follows: at rest, coronary flow is normal even in the presence of a narrowing of up to 85% diameter stenosis (Fig. 6.1).1 Stress, usually in the form of dynamic exercise or vasodilatation, results in an increase in coronary flow. In a normal coronary artery, flow increases 2- to 2.5-fold with dynamic exercise or by three- to fourfold with maximal coronary vasodilation.2–6 However, the increase in flow in a stenosed coronary is attenuated. Despite an increase in flow proximally, there is an increase in the pressure gradient across the stenosis, resulting in a drop in pressure and flow distal to the stenosis. This causes a heterogeneous distribution of blood flow during stress, with a greater increase in myocardial perfusion in the area subtended by the normal coronary artery relative to the myocardium supplied by the stenotic artery. In certain circumstances, coronary flow may actually decrease distal to the stenosis, resulting in subendocardial ischemia. This phenomenon of myocardial steal may occur in two circumstances. In the presence of a severe coronary stenosis, the coronary pressure distal to the stenosis may decrease enough during stress that it is insufficient to perfuse the endocardium, resulting in subendocardial ischemia despite an increase in total flow in the proximal epicardial artery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis: instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol 1974;33:87–94.
Holmberg S, Serzysko W, Varnauskas E. Coronary circulation during heavy exercise in control subjects and patients with coronary heart disease. Acta Med Scand 1971;190:465–480.
Heiss HW, Barmeyer J, Wink K, et al. Studies on the regulation of myocardial bloodflow in man: training effects on bloodflow and metabolism of the healthy heart at rest and during standardized heavy exercise. Basic Res Cardiol 1976;71:658–675.
Ferguson RJ, Cote P, Gauthier P, Bourassa MG. Changes in exercise coronary sinus blood flow with training in patients with angina pectoris. Circulation 1978;58:41–47.
Wilson RF, Laughlin DE, Ackell PH, et al. Transluminal, subselective measurement of coronary artery blood flow velocity and vasodilator reserve in man. Circulation 1985;72:82–92.
Rossen JD, Simonetti I, Marcus ML, Winniford MD. Coronary dilation with standard dose dipyridamole and dipyridamole combined with handgrip. Circulation 1989;79:566–572.
Gould KL. PET perfusion imaging and nuclear cardiology. J Nucl Med 1991;32:579–606.
Gould KL. Cardiac PET—state of the art. Circulation 1991;84(suppl):1-22–1-36.
Gould KL. Percent coronary stenosis: Battered gold standard, pernicious relic, or clinical practicality? J Am Coll Cardiol 1988;11:886–888.
Marcus ML, Skorton DJ, Johnson MR, Collins SM, Harrison DG, Kerber RE. Visual estimates of percent diameter coronary stenosis: “a battered gold standard.” J Am Coll Cardiol 1988;41:882–885.
White CW, Wright CB, Doty DB, et al. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? N Engl J Med 1984;310:819–824.
Marcus ML, Harrison DG, White CW, McPherson DD, Wilson RF, Kerber RE. Assessing the physiologic significance of coronary obstructions in patients: Importance of diffuse undetected atherosclerosis. Prog Cardiol Dis 1988;31:39–56.
Seiler C, Kirkeeide RL, Gould KL. Basic structure-function of the epicardial coronary vascular tree—the basis of quantitative coronary arteriography for diffuse coronary artery disease. J Clin Invest 1992;85:1987–2003.
Gould KL. Identifying and measuring the severity of coronary artery stenosis: quantitative coronary arteriography and positron emission tomography. Circulation 1988;68:237.
Gould KL. Quantitation of coronary stenosis in vivo. Circ Res 1985;57:341.
Kirkeeide RL, Gould KL, Parsel L. Assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation, VII: validation of coronary flow reserve as a single integrated functional measure of stenosis severity reflecting all its geometric dimensions. J Am Coll Cardiol 1986;7:103.
Gould KL. Coronary Artery Stenosis. New York. Elsevier Scientific, 1990.
Gould KL, Kirkeeide R, Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity, part I: relative and absolute coronary flow reserve during changing aortic pressure, part II: determination from the arteriographic stenosis dimensions under standardized conditions. J Am Coll Cardiol 1990;15:459.
McCall D, Zimmer LJ, Katy AM. Kinetics of thallium exchange in cultured rat cells. Circ Res 1985;56:370–376.
Weich HF, Strauss HW, Pitt B. Extraction of thallium-201 by the myocardium. Circulation 1977;56:188–191.
Goldhaber SZ, Newell JB, Alpert NM, Andrews E, Pohost GM, Ingwall JS. Effects of ischemic-like insult on myocardial thallium-201 accumulation. Circulation 1983;67:778–786.
Leppo JA, MacNeil PB, Moring AF, Apstein CS. Separate effects of ischemia, hypoxia and contractility on thallium-201 kinetics in rabbit myocardium. J Nucl Med 1986;27:66–74.
Pohost GM, Alpert NS, Ingwall JS, Strauss HW. Thallium redistribution: mechanisms and clinical utility. Semin Nucl Med 1980;20:70–93.
Leppo JA. Myocardial uptake of thallium and rubidium during alterations in perfusion and oxygenation in isolated rabbit hearts. J Nucl Med 1987;28:878–885.
Strauss HW, Harrison K, Langan VK, Lebowitz E, Pitt B. Thallium-201 for myocardial imaging: relation of thallium-201 to regional myocardial perfusion. Circulation 1975;51:641–645.
Chu A, Murdock RH, Cobb FR. Relationship between regional distribution of thallium-201 and myocardial blood flow in normal, acutely ischemic and infarcted myocardium. Am J Cardiol 1982;50:1141–1144.
Nielsen AP, Morris KG, Murdock RH, Bruno FP, Cobb FR. Linear relationship between the distribution of thallium-201 and blood flow in ischemic and nonischemic myocardium during exercise. Circulation 1980;61:797–801.
Pohost GM, Okada RD, O’Keefe DD, et al. Thallium redistribution in dogs with severe coronary artery stenosis of fixed caliper. Circ Res 1981;48:439–446.
Gewirtz H, O’Keefe DD, Pohost GM, Strauss HW, McIlduff JB, Daggett WM. The effect of ischemia on thallium-201 clearance from the myocardium. Circulation 1978;58:216–219.
Kaul S, Chester DA, Pohost GM, Strauss HW, Okada RD, Boucher CA. Influence of peak exercise heart rate on normal thallium-201 myocardial clearance. J Nucl Med 1986:2726–2730.
Brunken R, Tillisch J, Schwaiger M, et al. Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in infarct regions by positron emission tomography. Circulation 1986;73:951–963.
Brunken R, Schwaiger M, Grover-McKay M, Phelps ME, Tillisch J, Schelbert HR. Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. J Am Coll Cardiol 1987;10:557–567.
Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron emission tomography. N Engl J Med 1986;314:884–888.
Dilsizian V, Rocco TP, Freedman NM, Leon M, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990;323:141–146.
Dilsizian V, Smeltzer WR, Freedman NM, Dextras R, Bonow RO. Thallium reinjection after stress-reinjection imaging: does 24 hour delayed imaging after reinjection enhance detection of viable myocardium? Circulation 1991;83:1247–1255.
Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction: comparison of thallium scintigraphy with reinjection and PET imaging with 18F-Fluorodeoxyglucose. Circulation 1991;83:26–37.
Perrone-Filardi P, Bacharach SL, Dilizian V, Maurea S, Frank JA, Bonow RO. Regional left ventricular wall thickening: relation to regional uptake of 18Fluorodeoxyglucose and 201Tl in patients with chronic coronary artery disease. Circulation 1992;86:1125–1137.
Kitsiou AN, Srinivasan G, Quyyumi AA, et al. Stress-induced reversible and mild-to-moderate irreversible thallium defects: are they equally accurate for predicting recovery of regional left ventricular function after revascularization? Circulation 1998;98:501–508.
Kahn JK, McGhie AI, Akers MS, et al. Quantitative rotational tomography with 201Tl and 99mTc 2-methoxy-isobutyl-isonitrile. A direct comparison in normal individuals and patients with coronary artery disease. Circulation 1989;79:1282–1293.
Leppo JA, DePuey EG, Johnson LL. A review of cardiac imaging with sestamibi and teboroxime. J Nucl Med 1991;32:2012–2022.
Leppo JA, Meerdink DJ. Comparative myocardial extraction of two technetium-labeled BATO derivatives (SQ30217, SQ32014) and thallium. J Nucl Med 1990;31:67–74.
Gray WA, Gewirtz H. Comparison of 99mTc-Teboroxime with thallium for myocardial imaging in the presence of a coronary stenosis. Circulation 1991;84:1796–1807.
Stewart RE, Heyl B, O’Rourke RA, Blumhardt R, Miller DD. Demonstration of differential post-stenotic myocardial technetium-99m teboroxime clearance kinetics after experimental ischemia and hyperemic stress. J Nucl Med 1991;32:2000–2008.
Beanlands R, Muzik O, Nguyen N, Petry N, Schwaiger M. The relationship of the myocardial retention of technetium-99m teboroxime and myocardial blood flow. J Am Coll Cardiol 1992;20:712–719.
Fleming RM, Kirkeeide RL, Taegtmeyer H, Adyanthaya A, Cassidy DB, Goldstein RA. Comparison of technetium-99m teboroxime and thallium-201 tomography with automated coronary arteriography and thallium tomographic imaging. J Am Coll Cardiol 1991;17:1297–1302.
Beller GA, Sinusas AJ. Experimental studies of the physiologic properties of technetium-99m isonitriles. Am J Cardiol 1990;66:5E–8E.
Beanlands RS, Dawood F, Wen WH, et al. Are the kinetics of Technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? Circulation 1990;82:1802–1814.
Carvalho PA, Chui ML, Kronauge JF, et al. Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med 1992;33:1516–1522.
Kiat H, Maddahi J, Roy L, Friedman J, Berman DS. Comparison of Tc-99m-methoxyisobutyl isonitrile with Tl-201 imaging by planar and SPECT techniques for assessment of coronary disease. Am Heart J 1989;117:1–11.
Heller GV, Stowers SA, Hendel RC, et al. Clinical value of acute rest technetium-99m tetrofosmin tomographic myocardial perfusion imaging in patients with acute chest pain and nondiagnostic electrocardiograms. J Am Coll Cardiol 1998;31:1011–1017.
BilO’Deau L, Theroux P, Gregoire J, et al. Technetium-99m sestamibi tomography in patients with spontaneous chest pain: correlations with clinical, electrocardiographic and angiographic findings. J Am Coll Cardiol 1991;18:1684–1691.
Varetto T, Cantalupi D, Altieri A, et al. Emergency room technetium-99m sestamibi imaging to rule out acute myocardial ischemic events in patients with nondiagnostic electrocardiograms. J Am Coll Cardiol 1993;22:1804–1808.
Duca MD, Giri S, Wu AH, et al. Comparison of acute rest myocardial perfusion imaging and serum markers of myocardial injury in patients with chest pain syndromes. J Nucl Cardiol 1999;6:570–576.
Verani MS, Jeroudi MO, Mahmarian JJ, et al. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxy isobutyl isonitrile. J Am Coll Cardiol 1988;12:1573–1581.
Sinusas AJ, Trautman KA, Bergin JD, et al. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile. Circulation 1990;82:1424–1437.
Germano G, Kiat H, Kavanagh PB, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995;36:2138–2147.
DePuey EG, Rozanski A. Using gated technetium-99m sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact. J Nucl Med 1995;36:952–955.
Berman DS, Kiat HS, Van Train KF, et al. Myocardial perfusion imaging with technetium-99m-sestamibi: comparative analysis of available imaging protocols. J Nucl Med 1994;35:681–688.
Younes A, Songadele JA, Maublant J, et al. Mechanism of uptake of technetium-tetrofosmin. II: uptake into isolated adult rat heart mitochondria [published erratum appears in J Nucl Cardiol 1995;2:560]. J Nucl Cardiol 1995;2:327–333.
Platts EA, North TL, Pickett RD, Kelly JD. Mechanism of uptake of technetium-tetrofosmin. I: uptake into isolated adult rat ventricular myocytes and subcellular localization [published erratum appears in J Nucl Cardiol 1995;2:560]. J Nucl Cardiol 1995;2:316–326.
Kelly JD, Forster AM, Higley B, et al. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993;34:222–227.
Sinusas JA, Shi Q, Saltzberg MT, et al. Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia. J Nucl Med 1994;35:664–671.
Munch G, Neverve J, Matsunari I, et al. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease. J Nucl Med 1997;38:428–432.
Glover DK, Ruiz M, Yang JY, et al. Myocardial 99m-Tc-tetrofosmin uptake during adenosine-induced vasodilatation with either a critical or mild coronary stenosis: comparison with 2-1Tl and regional myocardial blood flow. Circulation 1997;96:2332–2338.
Shanoudy H, Raggi P, Beller GA, et al. Comparison of technetium-99m-tetrofosmin and thallium-201 single-photon emission computed tomographic imaging for detection of myocardial perfusion defects in patients with coronary artery disease. J Am Coll Cardiol 1998;31:331–337.
Matsunari I, Fujino S, Taki J, et al. Comparison of defect size between thallium-201 and technetium-99m tetrofosmin myocardial single-photon emission computed tomography in patients with single-vessel coronary artery disease. Am J Cardiol 1996;77:350–354.
Tamaki N, Takahashi N, Kawamoto M, et al. Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease. J Nucl Med 1994;35:594–600.
Rigo P, Leclercq B, Itti R, et al. Technetium-99m-tetrofosmin myocardial imaging: a comparison with thallium-201 and angiography. J Nucl Med 1994;35:587–593.
Zaret BL, Rigo P, Wackers FJ, et al. Myocardial perfusion imaging with 99mTc tetrofosmin: comparison to 201 Tl imaging and coronary angiography in a phase III multicenter trial. Tetrofosmin International Trial Study Group [see comments]. Circulation 1995;91:313–319.
Acampa W, Cuocolo A, Sullo P, et al. Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease. J Nucl Cardiol 1998;5:265–274.
Higginbotham MB. Cardiac performance during submaximal and maximal exercise in healthy persons. Heart Failure 1988;4:68–76.
Leppo JA. Dipyridamole-Thallium imaging: the lazy man’s stress test. J Nucl Med 1989;30:281–287.
Beller GA. Pharmacologic stress imaging. JAMA 1991;265:633–638.
Ranhosky A, Kempthorne-Rawson J, and the Intravenous Dipyridamole Thallium Imaging Study Group. The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Circulation 1990;81:1205–1209.
Miura M, Tominago S, Hashimoto K. Potentiation of reactive hyperemia in the coronary and femoral circulation by the selective use of 2, 5-bis-(diethanolamino)-4,8-dipiperidino (5,4-d) pyrimidine. Arzneium-Forschrift 1967;17:976–979.
Kubler W, Bretschneider HJ. Competitive inhibition of catalyzed adenosine diffusion as the mechanism of coronary dilating action of a pyrimido-pyrimidine derivative. Pflugers Arch 1964;280:141–157.
Afonso S, O’Brien GS. Mechanism of enhancement of adenosine action by dipyridamole and lidoflazine in dogs. Arch Int Pharmacodyn Ther 1971;194:181–196.
Fenton RA, Bruttig SP, Rubio R, Berne RM. Effect of adenosine on calcium uptake by intact and cultured vascular smooth muscle. Am J Physiol 1987;252:H598–604.
Fredholm BB, Gustafsson LH, Hedqvist P, Sollevi A. Adenosine in the regulation of neurotransmitter release in the peripheral nervous system. In: Berne RM, Rall TW, Rubio R, eds. Regulatory Function of Adenosine. The Hague: Martinus Nijhoff, 1983:479–495.
Rovetto MJ. Myocardial nucleotide transport. Am Rev Physiol 1985;47:605–616.
Hiefsen-Kadsk F, Pedersen AK. Pharmacokinetics of dipyridamole. Acta Pharmacol Toxicol 1979;44:391–399.
Fredholm BB, Persson CG. Xanthine derivatives and adenosine receptor antagonists. Eur J Pharmacol 1981;81:673–676.
Wilson RF, Wychek K, Christensen BV, Zimmer S, Laxson DD. Effects of adenosine on human coronary arterial circulation. Circulation 1990;82:1595–1606.
Christensen CW, Rosen LB, Gal RA, Haseeb M, Lassar TA, Port SC. Coronary vasodilator reserve: comparison of the effects of papaverine and adenosine on coronary flow, ventricular function, and myocardial metabolism. Circulation 1991;83:294–303.
Verani MS, Mahmarian JJ, Hixson JB, Boyce TM, Staudacher RA. Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and Thallium-201 scintigraphy in patients unable to exercise. Circulation 1990;82:80–87.
Coyne EP, Belvedere DA, Vande Streek PR, Weiland FL, Evans BB, Spaccavento LJ. Thallium-201 scintigraphy after intravenous infusion of adenosine compared with exercise: Thallium testing in the diagnosis of coronary artery disease. J Am Coll Cardiol 1991;17:1289–1294.
Nishimura S, Mahmanian JJ, Boyce TM, Verani MS. Quantitative Thallium-201 single photon emission computed tomography during maximal pharmacologic coronary vasodilation with adenosine for assessing coronary artery disease. J Am Coll Cardiol 1991;18:736–745.
Abreu A, Mahmarian JJ, Nishimura S, Boyce TM, Verani M. Tolerance and safety of pharmacologic coronary vasodilation with adenosine in association with thallium-201 scintigraphy in patients with suspected coronary artery disease. J Am Coll Cardiol 1991;18:730–735.
Glover DK, Ruiz M, Yang JY, et al. Pharmacological stress thallium scintigraphy with 2-(cyclohexylmethylidene)hydrazinoadenosine (WRC-0470), a novel, short-acting adenosine A2A receptor agonist. Circulation 1996;94:1726–1732.
Bertolet BD, Belardinelli L, Franco EA, et al. Selective attenuation by N-0861 (N6−endonorbornan-2-yl-9-methyladenine) of cardiac A1 adenosine receptor-mediated effects in humans. Circulation 1996;93:1871–1876.
Udelson JE, Heller GV, Wackers FJT, et al. Randomized, controlled dose-ranging study of the selective adenosine A2A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging. Circulation 2004;109:457–464.
Gould KL, Westcott RJ, Albro PC, Hamilton GW. Non-invasive assessment of coronary stenosis by myocardial imaging during pharmacologic coronary vasodilation II: clinical methodology and feasibility. Am J Cardiol 1978;41:279–287.
Casale PN, Guiney TE, Strauss HW, Boucher CA. Simultaneous low-level treadmill exercise and intravenous dipyridamole stress thallium imaging. Am J Cardiol 1988;62:799–802.
Brown G, Josephesen MA, Petersen RB, et al. Intravenous dipyridamole combined with isometric handgrip for near maximal acute increase in coronary flow in patients with coronary artery disease. Am J Cardiol 1981;48:1077–1085.
Stern S, Greenberg ID, Corne R. Effect of exercise supplementation on dipyridamole Thallium-201 image quality. J Nucl Med 1991;32:1559–1564.
De Puey EG. Exercise supplementation of dipyridamole for myocardial perfusion imaging. J Nucl Med 1991;32:1564–1568.
Ruffolo RR. Review: the pharmacology of dobutamine. Am J Med Sci 1987;294:244–248.
Meyer SL, Curry GC, Donsky MS, Twieg DB, Parkey RW, Willerson JT. Influence of dobutamine on hemodynamics and coronary flow in patients with and without coronary artery disease. Am J Cardiol 1976;38:103–108.
Willerson JT, Hutton I, Watson JT, Platt MR, Templeton GH. Influence of dobutamine on regional myocardial bloodflow and ventricular performance during acute and chronic myocardial ischemia in dogs. Circulation 1976;53:828–833.
McGillem MJ, Scott BS, DeBoe SF, Friedman HZ, Mancini GBJ. The effects of dopamine and dobutamine on regional function in the presence of rigid coronary stenoses and subcritical impairments of reactive hyperemia. Am Heart J 1988;115:970–977.
Fung AY, Gallagher KP, Buda AJ. The physiologic basis of dobutamine as compared with dipyridamole stress interventions in the assessment of critical coronary stenosis. Circulation 1987;76:943–951.
Pennell DJ, Underwood SR, Swanton RH, Walker JM, Ell PJ. Dobutamine thallium myocardial perfusion tomography. J Am Coll Cardiol 1991;18:1471–1479.
Elliot BM, Robison JG, Zellner JL, Hendrix GH. Dobutamine-201Tl imaging: assessing cardiac risks associated with vascular surgery. Circulation 1991;84(suppl 5):III-54–60.
Marwick T, Willemart B, D’Hondt AM, et al. Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion: comparison of dobutamine and adenosine using echocardiography and 99mTc-MIBI single photon emission computed tomography. Circulation 1993;87:345–354.
Hays JT, Mahmarian JJ, Cochran AJ, et al. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary disease unable to undergo exercise or vasodilator pharmacologic stress testing. J Am Coll Cardiol 1993;21: 1583–1590.
DePuey EG, Garcia EV. Updated Imaging Guidelines For Nuclear Cardiology Procedures, Part 1. J Nuc Cardiol 2001;8:G5–G58.
Fintel DJ, Links JM, Brinker JA, Frank TL, Parker M, Becker L. Improved diagnostic performance of exercise thallium-201 single photon emission computed tomography over planar imaging in the diagnosis of coronary artery disease: a receiver operating characteristic analysis. J Am Coll Cardiol 1989;13:600–612.
Berman DS, Kiat H, Friedman JD, et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dualisotope myocardial perfusion single-photon emission tomography: a clinical validation study. J Am Coll Cardiol 1993;22:1455–1464.
Berman DS, Hachamovich R, Kiat H, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995;26:639–647.
Clausen M, Bice AN, Civelek C, Hutchins GM, Wagner HN. Circumferential wall thickness measurements of the human left ventricle: reference data for thallium-201 single photon emission computed tomography. Am J Cardiol 1986;58:827–831.
Garcia EV, Van Train K, Maddahi J, et al. Quantification of rotational Thallium-201 myocardial tomography. J Nucl Med 1985;26:17–26.
DePasquale EE, Nody AC, DePuey EG, et al. Quantitative rotational thallium-201 tomography for identifying and localizing coronary artery disease. Circulation 1988;77:316–327.
Maddahi J, Van Train K, Prigent F, et al. Quantitative single photon emission computed thallium-201 tomography for detection and localization of coronary artery disease: Optimization and prospective validation of a new technique. J Am Coll Cardiol 1989;14:1689–1699.
DePuey EG, Garcia EV. Optimal specificity of thallium-201 SPECT through the recognition of imaging artifacts. J Nucl Med 1989;30:441–449.
Kiat H, Van Train KF, Friedman JD, et al. Quantitative stressredistribution imaging thallium-201 SPECT using prone imaging: methodologic development and validation. J Nucl Med 1992;33:1509–1515.
Cooper JA, Neumann PH, McCandless BK. Effect of patient motion on tomographic myocardial perfusion imaging. J Nucl Med 1992;33:1566–1571.
Matzer L, Kiat H, Friedman JD, Van Train K, Maddahi J, Berman DS. A new approach to the assessment of tomographic thallium-201 scintigraphy in patients with left bundle branch block. J Am Coll Cardiol 1991;17:1309–1317.
Wintergreen Summary: Panel on Instrumentation and Quantification. J Nucl Cardiol 1999;6:94–103.
Germano G, Erel J, Kiat H, et al. Quantitative LVEF and qualitative regional function from gated thallium-201 perfusion SPECT. J Nucl Med 1997;38:749–754.
Ficaro EP, Fessler JA, Shreve PD, et al. Simultaneous transmission emission myocardial perfusion: diagnostic accuracy of attenuation-corrected 99mTc-sestamibi, single-photon emission computed tomography. Circulation 1996;93:463–473.
Ficaro EP, Fessler JA, Ackermann RJ, et al. Simultaneous transmission-emission thallium-201 cardiac SPECT: effect of attenuation correction on myocardial tracer distribution. J Nucl Med 1995;36:921–931.
Kluge R, Sattler B, Seese A, et al. Attenuation correction by simultaneous emission-transmission myocardial single-photon emission tomography using a technetium-99m-labelled radiotracer: impact on diagnostic accuracy. Eur J Nucl Med 1997;24:1107–1114.
Gallowitsch HJ, Sykora J, Mikosch P, et al. Attenuationcorrected thallium-201 single-photon emission tomography using a gadolinium-153 moving line source: clinical value and the impact of attenuation correction on the extent and severity of perfusion abnormalities. Eur J Nucl Med 1998;25:220–228.
Hendel RC, Berman DS, Cullom SJ, et al. Multicenter clinical trial to evaluate the efficacy of correction for photon attenuation and scatter in SPECT myocardial perfusion imaging. Circulation 1999;99:2742–2749.
Links JM, Becker LC, Rigo P, et al. Combined corrections for attenuation, depth-dependent blur, and motion in cardiac SPECT: a multicenter trial. J Nucl Cardiol 2000;7:414–425.
Duvernoy CS, Ficaro EP, Karabajakian MZ, et al. Improved detection of left main coronary artery disease with attenuationcorrected SPECT. J Nucl Cardiol 2000;7:639–648.
Klocke FJ, Baird MG, Bateman TM, et al. AHA/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. http://www.acc.org/clinical/guidelines/radio/rni_fulltext.pdf, accessed April 16, 2005.
Hendel RC, Corbett JR, Cullom SJ, et al. The value and practice of attenuation correction for myocardial perfusion SPECT imaging: a joint position statement from the American Society of Nuclear Cardiology and the Society of Nuclear Medicine. J Nucl Cardiol 2002;9:135–143.
Bacharach SL. The new-generation positron emission tomography/computed tomographic scanners: implications for cardiac imaging. J Nucl Cardiol 2004;11:388–392.
Bergmann SR, Fox KAA, Rand AL, et al. Quantification of regional myocardial blood flow in vivo with H2 15O. Circulation 1984;70:724–728.
Knabb RM, Fox KAA, Sobel BE, et al. Characterization of the functional significance of subcritical stenosis with H2 15O and positron emission tomography. Circulation 1985;71:1271–1282.
Nienaber CA, Ratib O, Gambhir S, et al. A quantitative index of regional blood flow in canine myocardium derived noninvasively with N-13 ammonia and dynamic positron emission tomograph. J Am Coll Cardiol 1991;17:260–269.
Schelbert HR, Wisenberg G, Phelps ME, et al. Non-invasive assessment of coronary stenosis by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in man with intravenous N-l3 ammonia and positron computed tomography. Am J Cardiol 1982;49:1197–1207.
Gould KL, Goldstein RA, Mullani NA. Economic analysis of clinical positron emission tomography of the heart with rubidium-82. J Nucl Med 1989;30:707–717.
Schelbert HR, Phelps ME, Huang S, et al. N-13 ammonia as an indicator of myocardial blood flow, Circulation 1981;63:1259–1271.
Krivokapich J, Huang SC, Selin CE, et al. Fluorodeoxyglucose rate constants, lumped constant, and glucose metabolic rate in rabbit heart. Am J Physiol 1987;252:H777–H787.
Ratib O, Phelps, ME, Huang SC, et al. Positron emission tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med 1982;23:577–586.
Schon H, Schelbert HR, Najafi A, et al. C-11-labeled palmitic acid for noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. II. Kinetics of C-11-palmitic acid in acutely ischemic myocardium. Am Heart J 1982;1103:548–561.
Schelbert HR, Henze E, Schon H, et al. C-11-labeled palmitic acid for noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. III. In vivo demonstration of the effects of substrate availability on myocardial metabolism. Am Heart J 1983;105:492–504.
Sobel BE, Geltman EM Tiefenbrunn AJ, et al. Improvement of regional myocardial metabolism after coronary thrombolysis induced with tissue-type plasminogen activator or streptokinase. Circulation 1984;69:983–990.
Bergmann SR, Lerch RA, Fox KAA, et al. Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron emission tomography. Am J Med 1982;73:573–581.
Knabb RM, Bergmann SR, Fox KAA, et al. The temporal pattern of recovery of myocardial perfusion and metabolism delineated by positron emission tomography following coronary thrombolysis. J Nucl Med 1987;28:1563–1570.
Schelbert HR, Henze E, Schon H, et al. C-11-labeled palmitic acid for noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. III. In vivo demonstration of the effects of substrate availability on myocardial metabolism. Am Heart J 1983;105:492–504.
Schon H, Schelbert HR, Najafi A, et al. C-11-labeled palmitic acid for noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. II. Kinetics of C-11-palmitic acid in acutely ischemic myocardium. Am Heart J 1982;1103:548–561.
Brown M, Myears D, Bergmann S. Validity of estimates of myocardial oxidative metabolism with carbon-11-acetate and positron emission tomography despite altered patterns of substrate utilization. J Nucl Med 1989;30:187–193.
Brown M, Marshall D, Sobel B. Delineation of myocardial oxygen utilization with carbon-11-labeled acetate. Circulation 1987;76:687–696.
Brown M, Myears D, Bergmann S. Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11-acetate and positron emission tomography. J Am Coll Cardiol 1988;12:1054–1063.
Walsh M, Geltman E, Brown M, et al. Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11-acetate in patients with myocardial infarction. J Nucl Med 1989;30:1798–1808.
Buxton DB, Nienaber CA, Luxen A, et al. Noninvasive quantitation of regional myocardial oxygen consumption in vivo with [1–11C] acetate and dynamic positron emission tomography. Circulation 1989;79:134–142.
Armbrecht JJ, Buxton DB, Schelbert HR. Validation of [1–11C] acetate kinetics as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. Circulation 1990;81:1594–1605.
Lear JL. Relationship between myocardial clearance rates of carbon-11-acetate-derived radiolabeled and oxidative metabolism: physiologic basis and clinical significance (editorial). J Nucl Med 1991;32:1957–1060.
McCord ME, Bacharach SL, Bonow RO, Dilsizian V, Cuocolo A, Freedman N. Misalignment between PET transmission and emission scans: its effect on myocardial imaging. J Nucl Med 1992;33:1209–1213.
Shelbert HR, Wisenberg G, Phelps ME, et al. Non-invasive assessment of coronary artery stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation: VI. Detection of coronary artery disease in human beings with intra-venous N-13 ammonia and positron emission tomography. Am J Cardiol 1982;49:1197–1201.
Tamaki N, Yonekura Y, Senda M, et al. Value and limitation of stress 201Tl single photon emission tomography: comparison with nitrogen-13 ammonia positron emission tomography. J Nucl Med 1988;29:1181–1188.
Demer LL, Gould KL, Goldstein RA, et al. Assessment of coronary artery disease severity by positron emission tomography: comparison with quantitative coronary arteriography in 193 patients. Circulation 1989;79:825–835.
Go RT, Marwick TH, MacIntyre WJ, et al. A prospective comparison of rubidium-82 PET and thallium-210 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med 1990;31:1899–1905.
Stewart RE, Schwaiger M, Molina E, et al. Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. Am J Cardiol 1991;67:1303–1310.
Bonow RO, Berman DS, Gibbons RJ, et al. Cardiac positron emission tomography: a report for health professionals from the Committee on Advanced Cardiac Imaging and Technology on Clinical Cardiology, American Heart Association. Circulation 1991;84:447–454.
Bateman TM, Heller GV, McGhie AI, Friedman JD, Case JA, Bryngelson JR, Hertenstein GK, Moutray KL, Reid KJ, Collum SJ. Diagnostic Accuracy of Rest/Stress ECG-gated Rubidium-82 Myocardial Perfusion PET: Comparison with ECG-gated Tc-99m-Sestamibi SPECT. J Nucl Cardiol 2006;13:24–33.
Watson DD, Nelson JP, Gottlieb S. Rapid bolus injection of radioisotopes. Radiology 1973;106:347–352.
Berger JH, Mathay RA, Pytlik LM, Gottschalk A, Zaret BL. First-pass radionuclide assessment of right and left ventricular performance in patients with cardiac and pulmonary disease. Semin Nucl Med 1979;9:275–224.
Dymond DS, Elliot AT, Flatman W, et al. The clinical validation of gold-195m: a new short half-life radiopharmaceutical for rapid, sequential, first pass angiocardiography. J Am Coll Cardiol 1983;2:85–92.
Wackers FJ, Stein R, Pytlik L, et al. Gold-195m for serial first pass radionuclide angiocardiography during upright exercise in patients with coronary artery disease. J Am Coll Cardiol 1983;2:497–505.
Jones RH. Radionuclide angiocardiography. In: Marcus, Schelbert, Skorton, Wolf, eds. Cardiac Imaging—Principles and Practice. Philadelphia: WB Saunders, 1991:1006–1026.
Askenazi J, Amnberg DS, Korngold E, LaFarge CG, Maltz DL, Treves S. Quantitative radionuclide angiocardiography. Am J Cardiol 1976;97:382–387.
Treves S, Collins-Nakai RL. Radioactive tracers in congenital heart disease. Am J Cardiol 1976;38:711–721.
Gilday DL, DeSouza M. Pediatric nuclear cardiology. In: Come PC, ed. Diagnostic Cardiology, Noninvasive Imaging Techniques. Philadelphia: JB Lippincott, 1985:159–190.
Peter CA, Armstrong BE, Jones RH. Radionuclide quantitation of right-to-left intracardiac shunts in children. Circulation 1981;64:572–577.
Corbett JR, Jansen DE, Lewis SE, et al. Tomographic gated blood pool radionuclide ventriculography: analysis of wall motion and left ventricular volumes in patients with coronary artery disease. J Am Coll Cardiol 1985;6:349–358.
Gill JB, Moore RH, Tamaki N, et al. Multi-gated blood-pool tomography: new method for the assessment of left ventricular function. J Nucl Med 1986;12:1916–1924.
Maublant J, Bailly P, Mestas D, et al. Feasibility of gated single photon transaxial tomography of the cardiac blood pool. Radiology 1983;146:837–839.
Poliner LR, Dehmer GJ, Lewis SE, Parkey RW, Blomqvist CG, Willerson JT. Left ventricular performance in normal subjects: a comparison of the responses to exercise in the upright and supine position. Circulation 1980;62:528–534.
Manyari DE, Kostuk WJ. Left and right ventricular function at rest and during bicycle exercise in the supine and sitting positions in normal subjects and patients with coronary artery disease. Am J Cardiol 1983;51:36–42.
Freeman MR, Berman DS, Staniloff H, et al. Comparison of upright and supine bicycle exercise in the detection and evaluation of extent of coronary artery disease by equilibrium radionuclide ventriculography. Am Heart J 1981;102:182–189.
Higgenbotham MB, Morris KG, Coleman E, Cobb FR. Sexrelated differences in normal cardiac response to upright exercise. Circulation 1984;70:357–366.
Hanley PJ, Gibbons RJ, Zinsmeister AR, et al. Sex-related differences in cardiac response to supine exercise assessed by radionuclide angiography. J Am Coll Cardiol 1989;13:624–629.
Parker JA, Secker-Walker R, Hill R, Siegel BA, Potchen EJ. A new technique for the calculation of left ventricular ejection fraction. J Nucl Med 1972;13:585–592.
Dehmer GJ, Lewis SE, Hillis LD, et al. Nongeometric determination of left ventricular volumes from equilibrium blood pool scans. Am J Cardiol 1980;45:293–300.
Dehmer GJ, Firth BG, Hillis LD, Nicod P, Willerson JT, Lewis SE. Nongeometric determinations of right ventricular volumes from equilibrium blood pool scans. Am J Cardiol 1982;49:78–84.
Links JM, Becker LC, Shindledecker JG, et al. Measurement of absolute left ventricular volumes from gated blood pool studies. Circulation 1982;65:82–91.
Starling MR, Dell’Italia LJ, Walsh RA, Little WC, Benedetto AR, Nusynowitz ML. Accurate estimates of absolute left ventricular volumes from equilibrium radionuclide angiographic count data using a simple geometric attenuation correction. J Am Coll Cardiol 1984;3:789–798.
Dehmer GJ, Firth BG, Lewis SE, Willerson JT, Hillis LD. Direct measurement of cardiac output by gated equilibrium blood pool scintigraphy: validation of scintigraphic volume measurements by a non-geometric technique. Am J Cardiol 1981;47:1061–1067.
Konstam MA, Wynne J, Holman BL, Brown EJ, Neill JM, Kolowski RT. Use of equilibrium (gated) radionuclide ventriculography to quantitate left ventricular output in patients with and without left-sided valvular regurgitation. Circulation 1981;64:578–585.
Corbett JR, Jansen DE, Lewis SE, et al. Tomographic gated blood pool radionuclide ventriculography: analysis of wall motion and left ventricular volumes in patients with coronary artery disease. J Am Coll Cardiol 1985;6:349–358.
Rigo P, Alderson PO, Robertson RM, Becker LC, Wagner HN. Measurement of aortic and mitral regurgitation by gated blood pool scans. Circulation 1979;60:306–312.
Nicod P, Corbett JR, Firth BG, et al. Radionuclide techniques for valvular regurgitation index: comparison in patients with normal or depressed ventricular function. J Nucl Med 1982;23:763–769.
Makler PT, McCarthy DM, Velchik MG, Goldstein HA, Alavi A. Fourier amplitude ratio: a new way to assess valvular regurgitation. J Nucl Med 1983;24:204–207.
Bonow RO. Radionuclide angiographic evaluation of left ventricular diastolic function. Circulation 1991;84(suppl I):I-208–I215.
Okada RD, Kirshenbaum HD, Kushner FG, et al. Observer variance in the qualitative evaluation of left ventricular wall motion and the quantitation of left ventricular ejection fraction using rest and exercise multigated blood pool imaging. Circulation 1980;61:128–136.
Okada RD, Pohost GM, Nichols AB, et al. Left ventricular regional wall motion assessment by multigated and enddiastolic, end-systolic gated radionuclide left ventriculography. Am J Cardiol 1980;45:1211–1218.
Maddox DE, Holman BL, Wynne J, et al. Ejection fraction image: a non-invasive index of regional left ventricular wall motion. Am J Cardiol 1978;14:1230–1238.
Maddox DE, Wynne J, Uren R, et al. Regional ejection fraction: a quantitative radionuclide index of regional left ventricular performance. Circulation 1979;59:1001–1009.
Links LM, Douglass KH, Wagner HN. Patterns of ventricular emptying by Fourier analysis of gated blood-pool studies. J Nucl Med 1980;21:978–982.
Ratib O, Henze E, Schon H, Schelbert H. Phase analysis of radionuclide ventriculograms for the detection of coronary artery disease. Am Heart J 1982;104:1–12.
Walton S, Yiannikas J, Jarritt PH, Brown NJG, Swanton RH, Ell PJ. Phasic abnormalities of left ventricular emptying in coronary artery disease. Br Heart J 1981;46:250–253.
Bacharach SL, Green MV, Bonow RO, DeGraaf CN, Johnston GS. A method for objective evaluation of functional images. J Nucl Med 1982;23:285–290.
Links JM, Raichlen JS, Wagner HN, Reid PR. Assessment of the site of ventricular activation by Fourier analysis of gated blood pool studies. J Nucl Med 1985;26:27–32.
Botvinick E, Dunn R, Frais M, et al. The phase image: its relationship to patterns of contraction and conduction. Circulation 1982;65:551–560.
Botvinick E, Frais M, O’Connell W, et al. Phase image evaluation of patients with ventricular pre-excitation syndromes. J Am Coll Cardiol 1984;3:799–814.
Berger JH, Mathay RA, Pytlik LM, Gottschalk A, Zaret BL. First-pass radionuclide assessment of right and left ventricular performance in patients with cardiac and pulmonary disease. Semin Nucl Med 1979;9:275–294.
Maddahi J, Berman DS, Masouka DT, et al. A new technique for assessing right ventricular ejection fraction using rapid multiple-gated equilibrium cardiac blood pool scintigraphy. Description, validation and findings in chronic coronary artery disease. Circulation 1979;60:581–589.
Rigo P, Murray M, Taylor D, et al. Right ventricular dysfunction in patients with acute inferior infarction. Circulation 1975;32:268–274.
Slutsky R, Hooper W, Gerber K. Assessment of right ventricular function at rest and during exercise in patients with coronary heart disease: a new approach using equilibrium radionuclide ventriculography. Am J Cardiol 1980;45:63–71.
Starling MR, Dell’Italia LJ, Chaudhuri TK, Boros BL, O’Rourke RA. First transit and equilibrium radionuclide angiocardiography in patients with inferior transmural myocardial infarction: criteria for diagnosis of associated hemodynamically significant right ventricular infarction. J Am Coll Cardiol 1984;4:923–930.
Winzelberg CG, Boucher CA, Pohost GM, et al. Right ventricular function in aortic and mitral disease: relation of gated firstpass radionuclide angiography to clinical and hemodynamic findings. Chest 1981;79:520–528.
Goldberg MJ, Mantel J, Freidin M, Ruskin R, Rubentire M. Intravenous xenon-133 for determination of radionuclide first pass right ventricular ejection fraction. Am J Cardiol 1981;47:626–630.
Martin W, Tweddel A, McGhie I, Hutton I. Gated Xenon scans for right ventricular function. J Nucl Med 1986;27:609–615.
McGhie I, Martin W, Tweddel A, Hutton I. Assessment of right ventricular function in acute inferior myocardial infarction using 133-Xenon imaging. Int J Cardiol 1989;22:195–202.
Ham HR, Piepz A, Vandevivere J, Guillaume M, Goethals P, Lenaers A. The evaluation of right ventricular performance using krypton-81m. Clin Nucl Med 1983;8:257–260.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag London Limited
About this chapter
Cite this chapter
McGhie, A.I., Gould, K.L., Willerson, J.T. (2007). Nuclear Cardiology. In: Willerson, J.T., Wellens, H.J.J., Cohn, J.N., Holmes, D.R. (eds) Cardiovascular Medicine. Springer, London. https://doi.org/10.1007/978-1-84628-715-2_6
Download citation
DOI: https://doi.org/10.1007/978-1-84628-715-2_6
Publisher Name: Springer, London
Print ISBN: 978-1-84628-188-4
Online ISBN: 978-1-84628-715-2
eBook Packages: MedicineMedicine (R0)